BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$962M |
| 2 |
Amazon
AMZN
|
+$682M |
| 3 |
Apple
AAPL
|
+$231M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$200M |
| 5 |
Broadcom
AVGO
|
+$172M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.19B |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$457M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$421M |
| 4 |
Motorola Solutions
MSI
|
+$353M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$323M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Financials | 9.56% |
| 4 | Healthcare | 8.43% |
| 5 | Communication Services | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
2026
Ellington Financial
EFC
$1.34B
| $796K | ﹤0.01% |
46,563
-4,145
| -8% | -$70.8K |
|
|
FOCS
2027
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $793K | ﹤0.01% |
13,286
+1,643
| +14% | +$98.1K |
|
2028
Corcept Therapeutics
CORT
$7.68B
| $793K | ﹤0.01% |
40,068
-58,957
| -60% | -$1.17M |
|
2029
Advanced Drainage Systems
WMS
$11B
| $791K | ﹤0.01% |
5,813
-25,120
| -81% | -$3.42M |
|
2030
St. Joe Company
JOE
$3.01B
| $790K | ﹤0.01% |
15,187
-17,228
| -53% | -$897K |
|
|
PGRE
2031
Paramount Group
PGRE
$1.57B
| $790K | ﹤0.01% |
94,778
-9,083
| -9% | -$75.8K |
|
2032
Ichor Holdings
ICHR
$579M
| $789K | ﹤0.01% |
17,146
-11,974
| -41% | -$551K |
|
2033
Shenandoah Telecom
SHEN
$744M
| $788K | ﹤0.01% |
30,902
-20,454
| -40% | -$522K |
|
2034
HSBC
HSBC
$238B
| $785K | ﹤0.01% |
26,048
+24,579
| +1,673% | +$741K |
|
2035
Churchill Downs
CHDN
$6.75B
| $784K | ﹤0.01% |
6,512
-470
| -7% | -$56.6K |
|
|
ITCI
2036
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $782K | ﹤0.01% |
14,944
+2,290
| +18% | +$120K |
|
2037
Levi Strauss
LEVI
$8.67B
| $782K | ﹤0.01% |
31,226
+14,019
| +81% | +$351K |
|
2038
Empire State Realty Trust
ESRT
$1.34B
| $780K | ﹤0.01% |
87,618
-1,585
| -2% | -$14.1K |
|
2039
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.3B
| $778K | ﹤0.01% |
7,185
+1,118
| +18% | +$121K |
|
2040
Carter's
CRI
$1.08B
| $778K | ﹤0.01% |
7,682
-1,086
| -12% | -$110K |
|
2041
Atara Biotherapeutics
ATRA
$85.1M
| $775K | ﹤0.01% |
1,968
+804
| +69% | +$317K |
|
2042
Pitney Bowes
PBI
$1.96B
| $772K | ﹤0.01% |
116,497
-100,086
| -46% | -$664K |
|
2043
Iovance Biotherapeutics
IOVA
$821M
| $772K | ﹤0.01% |
40,456
-30,919
| -43% | -$590K |
|
2044
Impinj
PI
$5.2B
| $770K | ﹤0.01% |
8,680
-90,689
| -91% | -$8.04M |
|
2045
Cheniere Energy
CQP
$25.2B
| $769K | ﹤0.01% |
18,207
+5,933
| +48% | +$251K |
|
2046
Enviri
NVRI
$983M
| $767K | ﹤0.01% |
45,924
-35,534
| -44% | -$594K |
|
2047
TriCo Bancshares
TCBK
$1.48B
| $767K | ﹤0.01% |
17,847
+10,112
| +131% | +$434K |
|
2048
Evolent Health
EVH
$1.05B
| $765K | ﹤0.01% |
27,665
+8,976
| +48% | +$248K |
|
|
MNR
2049
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $762K | ﹤0.01% |
36,265
+6,036
| +20% | +$127K |
|
2050
iRhythm Technologies
IRTC
$5.78B
| $758K | ﹤0.01% |
6,437
+371
| +6% | +$43.7K |
|